midostaurin
6 abstracts
Abstract
Multi-drug algorithm to accurately predict best first-line treatments in newly-diagnosed acute myeloid leukemia (AML).Org: Macclesfield, United Kingdom, Princess Margaret Hospital, University Health Network,
Abstract
Evaluation of the toxicity and outcomes of the combination of midostaurin and CLAG-M in patients with FLT3-mutated acute myeloid leukemia (AML): A multi-center retrospective analysis.Org: University of Washington/Fred Hutchison Cancer Center,
Abstract
Disparities in uptake of novel therapies for acute myeloid leukemia.Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Dana-Farber Cancer Institute,
Abstract
Gilteritinib or venetoclax in relapsed or refractory FLT3mut acute myeloid leukemia.Org: VCU School of Medicine, VCU Massey Cancer Center, VCU Department of Internal Medicine, VCU Department of Biostatistics,